Literature DB >> 18937080

Giant cell lung carcinoma in a man with acquired immunodeficiency syndrome.

Takahide Kodama1, Kunihiko Miyazaki, Hiroaki Satoh, Shigemi Hitomi, Morio Ohtsuka.   

Abstract

A 66-year-old man, who was discovered to have human immunodeficiency virus (HIV) infection 22 months previously and was treated with highly active antiretroviral (HAART) therapy, developed giant cell carcinoma of the lung. In English literature, this is the first case of such cell type of lung cancer during HAART therapy. Since giant cell carcinoma of the lung occurs mainly in elderly men who smoke heavily, there may not be a possibility that the HIV or HAART was causative in our patient.

Entities:  

Mesh:

Year:  2008        PMID: 18937080     DOI: 10.1007/s12032-008-9103-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  [Giant cell pulmonary carcinoma in a patient with HIV infection].

Authors:  B Sopeña; J L García-Tejedor; J de la Fuente; A Rivera; C Martínez-Vázquez
Journal:  An Med Interna       Date:  2001-06

2.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors.

Authors:  U Tirelli; M Spina; S Sandri; D Serraino; C Gobitti; M Fasan; A Sinicco; P Garavelli; A L Ridolfo; E Vaccher
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

4.  Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma.

Authors:  Y L Chang; Y C Lee; J Y Shih; C T Wu
Journal:  Lung Cancer       Date:  2001-10       Impact factor: 5.705

5.  Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.

Authors:  Roger Hakimian; Hongbin Fang; Leno Thomas; Martin J Edelman
Journal:  J Thorac Oncol       Date:  2007-04       Impact factor: 15.609

6.  Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.

Authors:  Giulio Rossi; Alberto Cavazza; Nathalie Sturm; Mario Migaldi; Nicola Facciolongo; Lucia Longo; Antonio Maiorana; Elisabeth Brambilla
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

7.  Palliative chemotherapy for pulmonary pleomorphic carcinoma.

Authors:  Hyun-Mi Bae; Hye Sook Min; Se-Hoon Lee; Dong-Wan Kim; Doo Hyun Chung; Jong-Seok Lee; Young Whan Kim; Dae Seog Heo
Journal:  Lung Cancer       Date:  2007-06-18       Impact factor: 5.705

8.  Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.

Authors:  Takahiro Mochizuki; Genichiro Ishii; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Tetsuya Mizuno; Tomoyuki Yokose; Kazuya Suzuki; Atsushi Ochiai
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

9.  Clinicopathological investigation of pulmonary pleomorphic carcinoma.

Authors:  Satoshi Yamamoto; Daisuke Hamatake; Takao Ueno; Takao Higuchi; Masahumi Hiratsuka; Takeshi Shiraishi; Akinori Iwasaki; Takayuki Shirakusa
Journal:  Eur J Cardiothorac Surg       Date:  2007-10-17       Impact factor: 4.191

10.  Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings.

Authors:  Tae Hoon Kim; Sang Jin Kim; Young Hoon Ryu; Hyun Ju Lee; Jin Mo Goo; Jung-Gi Im; Hyung Joong Kim; Doo Yun Lee; Sang Ho Cho; Kyu Ok Choe
Journal:  Radiology       Date:  2004-06-23       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.